Image source: Getty Images. In November, the stocks of three out of the four major tobacco companies, namely Philip Morris International, British American Tobacco, and Imperial Brands, all experienced a surge in prices. This upward trend continued into early December. However, Japan Tobacco's stock price has consistently been in decline since reaching an all-time high on November 24th.
The stock price of PMI International has been consistently increasing since December, with a cumulative increase of 6.8%. Source: Yahoo Finance.
The stock price of British American Tobacco (BAT) has increased by 4.7%, rising from $40.4 to $42.31, according to Yahoo Finance.
The Empire Tobacco saw a slight decline towards the end of November, but has since continued to rise according to a graph from Yahoo Finance.
On November 24th, Japanese tobacco began to experience a continuous decline from its historic high of 2,831.5 Japanese yen. Source: Yahoo Finance.
Additionally, Altria's stock price has increased for five consecutive days, with a rise of 6.4%, while the price of South Korean tobacco giant KT&G has been fluctuating for the past month.
Source: Yahoo Finance. Written by Zhang Hongxu.
On December 6, 2FIRSTS will release a special report on the latest trends in the tobacco industry. Follow-up content will be available on the 2FIRSTS app. Scan the QR code below to download the app.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
